Skip to content

Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders

Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders - Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy and Movement Disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000059304
Enrollment
20
Registered
2025-10-06
Start date
2024-10-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory epilepsy, parkinson&#39

Interventions

None listed

Sponsors

Keio University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with drug-resistant epilepsy or movement disorders, including Parkinson's disease, essential tremor, or dystonia, who are indicated for intracranial electrode implantation at the Department of Neurosurgery, Keio University School of Medicine. Patients who provide written informed consent to participate in this study. For minors or adults with insufficient decision-making capacity, written consent will be obtained from their legally authorized representative.

Exclusion criteria

Exclusion criteria: Patients who develop severe postoperative complications following electrode implantation. Patients deemed by the principal investigator or co-investigators to be unsuitable for participation in this study for any other reason.

Design outcomes

Primary

MeasureTime frame
Primary Outcome Measures (and Their Indicators / Evaluation Methods): To examine the relationship between electrophysiological activity at individual electrodes or functional connectivity across multiple brain regions and postoperative outcomes, including seizure control and improvement in motor symptoms. EEG/LFP data obtained from the implanted electrodes will be analyzed offline to assess correlations with clinical data.

Secondary

MeasureTime frame
Secondary Outcome Measures (and Their Indicators, Evaluation Methods): Accuracy of electrode implantation, to be evaluated using patient's medical records and imaging data.

Countries

Japan

Contacts

Public ContactKenzo Kosugi

Keio University Hospital Department of Neurosurgery

kensan03977@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026